‘Nightmare Bacteria’ Stalk U.S. Hospitals
The Centers for Disease Control and Prevention found antibiotic-resistant bacteria whose spread has “outpaced” efforts to contain them.
La FDA reducirá la nicotina en cigarrillos, para ayudar a fumadores a dejar el hábito
Autoridades aseguran que este plan ayudará a que los fumadores dejen el hábito, logrará que 33 millones de personas que ahora son menores ni siquiera se acerquen al tabaco, y salvará 8 millones de vidas.
FDA Moves To Cut Nicotine In Cigarettes, Helping Smokers Kick Habit
In a historic move, the Food and Drug Administration stated its intent Thursday to require tobacco companies to cut nicotine levels in their products to make them less addictive. Stripping cigarettes of addictive power could lead an estimated 5 million adults to quit smoking within a year of the plan.
¿Nunca es tarde para operar? Las cirugías al final de la vida son comunes y costosas
Muchos abuelitos se exponen a procedimientos que hacen más mal que bien, afectando su calidad de vida en el poco tiempo que les queda de vida.
Never Too Late To Operate? Surgery Near End Of Life Is Common, Costly
Nearly 1 in 3 Medicare patients undergo an operation in their final year of life.
FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’
In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.
Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Tanta atención que duele: terapias y cirugías innecesarias agregan dolor y enfermedad
Las pruebas excesivas de cáncer de tiroides, próstata, seno y piel lleva a muchas personas mayores a someterse a tratamientos que no prolongarán sus vidas, pero que pueden causar dolor y sufrimiento innecesarios.
So Much Care It Hurts: Unneeded Scans, Therapy, Surgery Only Add To Patients’ Ills
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.